Share Email Print

Proceedings Paper

In-stent neoatherosclerosis: are first generation drug eluting stents different than bare metal stents? An optical coherence tomography study
Author(s): Antonios Karanasos; Karen Witberg; Jurgen Ligthart; Konstantinos Toutouzas; Joost Daemen; Gijs van Soest; Muthukaruppan Gnanadesigan; Nicholas van Mieghem; Felix Zijlstra; Evelyn Regar
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Purpose: In-stent neoatherosclerosis has been recognised in pathologic specimens of bare metal stents (BMS), and recently in first generation drug eluting stents (1st-DES), as well. However, in vivo data are scarce. By optical coherence tomography, we investigated the incidence and morphological characteristics of neoatherosclerosis (NA) very late after BMS or 1st-DES implantation. Methods: From 1/1/2007 to 31/1/2012, 52 patients from two institutions underwent >24 months follow-up OCT assessment of a BMS or a 1st-DES (13 BMS – 39 1st-DES). NA was characterized using criteria for native atherosclerosis. Results: BMS had longer follow-up interval but no differences in clinical presentation at follow-up. No significant differences were evident in the incidence of NA, neointimal rupture, lipid content, neovascularization or macrophage infiltration between BMS and 1st-DES. There was however a trend for lower fibrous cap thickness (FCT) and for higher calcification in BMS (FCT: 51±31 μm vs. 92±59 μm, p=0.057; calcifications: 46.2% vs. 15.4%, p=0.051). 1st-DES with neoatherosclerosis had longer interval from implantation compared to 1st-DES with homogeneous coverage [Median 71 months (range 25-130) vs. 57 months (24-68), p<0.05], but there was no difference for BMS with or without neoatherosclerosis [Median 125 months (range 90-201) vs. 168 months (132-168), p=0.63]. Conclusions: The incidence and morphological characteristics of NA are similar between 1st-DES and BMS of more prolonged follow-up. Our findings suggest a time-dependent pattern in the incidence of NA in 1st-DES with 2-11 years follow-up.

Paper Details

Date Published: 8 March 2013
PDF: 13 pages
Proc. SPIE 8565, Photonic Therapeutics and Diagnostics IX, 856543 (8 March 2013); doi: 10.1117/12.2006341
Show Author Affiliations
Antonios Karanasos, Erasmus Medical Ctr. (Netherlands)
Karen Witberg, Erasmus Medical Ctr. (Netherlands)
Jurgen Ligthart, Erasmus Medical Ctr. (Netherlands)
Konstantinos Toutouzas, Hippokration Hospital (Netherlands)
Joost Daemen, Erasmus Medical Ctr. (Netherlands)
Gijs van Soest, Erasmus Medical Ctr. (Netherlands)
Muthukaruppan Gnanadesigan, Erasmus Medical Ctr. (Netherlands)
Nicholas van Mieghem, Erasmus Medical Ctr. (Netherlands)
Felix Zijlstra, Erasmus Medical Ctr. (Netherlands)
Evelyn Regar, Erasmus Medical Ctr. (Netherlands)

Published in SPIE Proceedings Vol. 8565:
Photonic Therapeutics and Diagnostics IX
Andreas Mandelis; Brian Jet-Fei Wong; Anita Mahadevan-Jansen; Henry Hirschberg M.D.; Hyun Wook Kang; Nikiforos Kollias; Melissa J. Suter; Kenton W. Gregory M.D.; Guillermo J. Tearney M.D.; Stephen Lam; Bernard Choi; Steen J. Madsen; Bodo E. Knudsen M.D.; E. Duco Jansen; Justus F. Ilgner M.D.; Haishan Zeng; Matthew Brenner; Laura Marcu, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?